SEC Form 4 · accession 0001179110-18-008669
Celldex Therapeutics, Inc. · CLDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tibor Keler
Officer — Executive VP & CSO
Period of report
Jun 15, 2018
Accepted (ET)
Jun 18, 2018 · 8:15 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000744218
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 per share | Jun 15, 2018 | P | 16,500 | $0.5929 | A | 35,368 | D |
Table II — derivative securities
No Table II lines on this filing.